Suppr超能文献

靶向死亡受体 5 的新型 N 末端表位触发肿瘤细胞死亡。

Targeting a novel N-terminal epitope of death receptor 5 triggers tumor cell death.

机构信息

National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, 5 Dong Dan San Tiao, Beijing 100005, China.

出版信息

J Biol Chem. 2010 Mar 19;285(12):8953-66. doi: 10.1074/jbc.M109.070680. Epub 2010 Jan 27.

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand receptors death receptor (DR) 4 and DR5 are potential targets for antibody-based cancer therapy. Activation of the proapoptotic DR5 in various cancer cells triggers the extrinsic and/or intrinsic pathway of apoptosis. It has been shown that there are several functional domains in the DR5 extracellular domain. The cysteine-rich domains of DR5 have a conservative role in tumor necrosis factor-related apoptosis-inducing ligand-DR5-mediated apoptosis, and the pre-ligand assembly domain within the N1-cap contributes to the ligand-independent formation of receptor complexes. However, the role of the N-terminal region (NTR) preceding the N1-cap of DR5 remains unclear. In this study, we demonstrate that NTR could mediate DR5 activation that transmits an apoptotic signal when bound to a specific agonistic monoclonal antibody. A novel epitope in the NTR of DR5 was identified by peptide array. Antibodies against the antigenic determinant showed high affinities for DR5 and triggered caspase activation in a time-dependent manner, suggesting the NTR of DR5 might function as a potential death-inducing region. Moreover, permutation analysis showed that Leu(6) was pivotal for the interaction of DR5 and the agonistic antibody. Synthetic wild-type epitopes eliminated the cytotoxicity of all three agonistic monoclonal antibodies, AD5-10, Adie-1, and Adie-2. These results indicate that the NTR of DR5 could be a potential target site for the development of new strategies for cancer immunotherapy. Also, our findings expand the current knowledge about DR5 extracellular functional domains and provide insights into the mechanism of DR5-mediated cell death.

摘要

肿瘤坏死因子相关凋亡诱导配体受体死亡受体 (DR)4 和 DR5 是抗体为基础的癌症治疗的潜在靶点。在各种癌细胞中,促凋亡 DR5 的激活触发了外在和/或内在的凋亡途径。已经表明,DR5 的细胞外结构域中有几个功能域。DR5 富含半胱氨酸的结构域在肿瘤坏死因子相关凋亡诱导配体-DR5 介导的凋亡中具有保守作用,而 N1 帽内的前配体组装结构域有助于配体独立的受体复合物形成。然而,DR5 的 N 端区域 (NTR) 在前 N1 帽之前的作用尚不清楚。在这项研究中,我们证明了 NTR 可以介导 DR5 的激活,当与特异性激动性单克隆抗体结合时,它会传递凋亡信号。通过肽阵列鉴定了 DR5 的 NTR 中的一个新表位。针对抗原决定簇的抗体与 DR5 具有高亲和力,并以时间依赖性方式触发半胱天冬酶的激活,这表明 DR5 的 NTR 可能作为潜在的死亡诱导区域发挥作用。此外,置换分析表明,亮氨酸 (Leu)6 对于 DR5 和激动性抗体的相互作用至关重要。合成的野生型表位消除了所有三种激动性单克隆抗体 AD5-10、Adie-1 和 Adie-2 的细胞毒性。这些结果表明,DR5 的 NTR 可能是开发癌症免疫治疗新策略的潜在靶点。此外,我们的发现扩展了目前对 DR5 细胞外功能域的认识,并为 DR5 介导的细胞死亡机制提供了深入了解。

相似文献

1
Targeting a novel N-terminal epitope of death receptor 5 triggers tumor cell death.
J Biol Chem. 2010 Mar 19;285(12):8953-66. doi: 10.1074/jbc.M109.070680. Epub 2010 Jan 27.
4
Structural and functional analysis of the N-terminal region of death receptor 5.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011 Feb;33(1):33-8. doi: 10.3881/j.issn.1000-503X.2011.01.008.
6
Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.
J Biol Chem. 2004 Dec 31;279(53):55594-601. doi: 10.1074/jbc.M401056200. Epub 2004 Oct 14.
8
TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5.
J Mol Med (Berl). 2010 Jul;88(7):729-40. doi: 10.1007/s00109-010-0619-0. Epub 2010 Mar 31.
9
Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):543-52. doi: 10.1016/j.ijrobp.2008.06.1902.
10
DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based design.
J Biol Chem. 2008 Jul 18;283(29):20560-8. doi: 10.1074/jbc.M800457200. Epub 2008 May 12.

引用本文的文献

1
A novel anti-DR5 antibody-drug conjugate possesses a high-potential therapeutic efficacy for leukemia and solid tumors.
Theranostics. 2019 Jul 13;9(18):5412-5423. doi: 10.7150/thno.33598. eCollection 2019.
2
DNA methylation profiling across the spectrum of HPV-associated anal squamous neoplasia.
PLoS One. 2012;7(11):e50533. doi: 10.1371/journal.pone.0050533. Epub 2012 Nov 30.
3
The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytes.
Free Radic Biol Med. 2012 May 1;52(9):1911-7. doi: 10.1016/j.freeradbiomed.2012.02.049. Epub 2012 Mar 8.

本文引用的文献

2
Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.
Cell. 2009 Jun 12;137(6):1100-11. doi: 10.1016/j.cell.2009.05.021.
3
RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis.
Science. 2009 Jul 17;325(5938):332-6. doi: 10.1126/science.1172308. Epub 2009 Jun 4.
5
Knockdown of c-FLIP(L) enhanced AD5-10 anti-death receptor 5 monoclonal antibody-induced apoptosis in human lung cancer cells.
Cancer Sci. 2009 May;100(5):940-7. doi: 10.1111/j.1349-7006.2009.01119.x. Epub 2009 Feb 19.
6
The TRAIL apoptotic pathway in cancer onset, progression and therapy.
Nat Rev Cancer. 2008 Oct;8(10):782-98. doi: 10.1038/nrc2465.
9
Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells.
J Biol Chem. 2008 Jul 11;283(28):19665-77. doi: 10.1074/jbc.M710169200. Epub 2008 Mar 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验